Why Valeant Pharmaceuticals International鈥檚 new CEO may signal a shift from 鈥榙isruptor鈥� to 鈥榩lain vanilla鈥�
聽Less than a year ago聽Valeant Pharmaceuticals International Inc.鈥檚 CEO Michael Pearson represented a disruption to big pharma by coming from outside the industry, using aggressive acquisitions and strategic business tactics to grow the company to a global giant. 聽
Now the company has hired Joseph Papa as the new CEO, a 35-year pharmaceutical industry veteran with a history of taking a balanced approach to business. If the past few months of Pearson鈥檚 tenure can be described as rocky road, Papa could help bring a new flavour to Valeant.
鈥淗e鈥檚 plain vanilla,鈥澛爏aid Robert David,聽a professor at 平特五不中鈥檚 Desautels Faculty of Management.聽
鈥淚 think plain vanilla isn鈥檛 such a bad thing at this time for this company. It signals stability as opposed to disruption.鈥澛�
Read full article: , 25 April, 2016聽
Feedback
For more information or if you would like to report an error, please web.desautels [at] mcgill.ca (subject: Website%20News%20Comments) (contact us).
